• Careers
  • Investors
  • News
  • Partnering
  • Contact Us
 
  • Home
  • Our Products
    • Recent Products
    • Consumer Products
    • Medical Devices & Diagnostics
    • Prescription Products
    • Product Coupons
  • Our Caring
    • Our Stories
    • Our Giving
    • Our Responsibility
    • Protecting Our People
    • Company Initiatives
  • Our Company
    • Our Credo Values
    • Our Management Approach
    • Our Citizenship
    • Corporate Governance
    • Company Structure
    • Our People & Diversity
    • Company Publications
    • Our History
  • News
    • All News
    • Corporate News
    • Product And Operating Company News
    • Financial News
    • Media Contacts
    • Product And Operating Company News Archive
  • Text Size
  • Text Only
  • Email to a Friend
  • Printer Friendly
  • RSS

Product and Operating Company News

Need to know more about a new skin care product? A new surgical device? A new pain relief medication? You can search here for the information you need from a Johnson & Johnson company.

< Prev | | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | .... 34 Next >
Janssen Research & Development Submits Complete Response to the U.S. FDA on XARELTO® (rivaroxaban) for the Reduction of Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome

September 07, 2012

Soccer Stars Alex Morgan And Cobi Jones Team Up With Depuy Mitek To Kick Off National Sports Injury Prevention Program

September 06, 2012

U.S. FDA Grants Priority Review to Bedaquiline (TMC207) for Multi-Drug Resistant Tuberculosis Treatment

September 05, 2012

Healthy Vision & Contact Lenses – New Educational Resource Offers Important Advice on Safe Wear And Care Of Contact Lenses

September 05, 2012

Janssen-Cilag International NV (Janssen) Submits European Marketing Authorisation Application for Investigational Multi-Drug Resistant Tuberculosis Treatment Bedaquiline

August 31, 2012

Janssen Pharmaceuticals, Inc. announces RISPERDAL® consumer protection settlement with 36 states and the District of Columbia

August 30, 2012

< Prev | | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | .... 34 Next >
  • Accessibility
  • Sitemap
  • Privacy Policy
  • Legal Notice
  • Employees
This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2013. All Rights Reserved.
  • Find us at
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • Employees
  • Careers
  • Investors
  • News
  • Partnering
  • Contact Us
Johnson & Johnson
  • Home
  • Our Products
  • Our Caring
  • Our Company
  • All News
  • Corporate News
  • Product And Operating Company News
  • Financial News
  • Media Contacts
  • Product And Operating Company News Archive
  • Text Size
  • Graphic Version
  • Email to a Friend
  • Printer Friendly
  • RSS

Product and Operating Company News

Need to know more about a new skin care product? A new surgical device? A new pain relief medication? You can search here for the information you need from a Johnson & Johnson company.

This section contains multiple pages. Click on each page number to advance the page.
< Prev | | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | .... 34 Next >
Janssen Research & Development Submits Complete Response to the U.S. FDA on XARELTO® (rivaroxaban) for the Reduction of Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome

September 07, 2012

Soccer Stars Alex Morgan And Cobi Jones Team Up With Depuy Mitek To Kick Off National Sports Injury Prevention Program

September 06, 2012

U.S. FDA Grants Priority Review to Bedaquiline (TMC207) for Multi-Drug Resistant Tuberculosis Treatment

September 05, 2012

Healthy Vision & Contact Lenses – New Educational Resource Offers Important Advice on Safe Wear And Care Of Contact Lenses

September 05, 2012

Janssen-Cilag International NV (Janssen) Submits European Marketing Authorisation Application for Investigational Multi-Drug Resistant Tuberculosis Treatment Bedaquiline

August 31, 2012

Janssen Pharmaceuticals, Inc. announces RISPERDAL® consumer protection settlement with 36 states and the District of Columbia

August 30, 2012

< Prev | | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | .... 34 Next >
  • Accessibility
  • Sitemap
  • Privacy Policy
  • Legal Notice
  • Employees
This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2013. All Rights Reserved.
  • Find us at
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •